Cargando…
RUNX2 expression in thyroid and breast cancer requires the cooperation of three non-redundant enhancers under the control of BRD4 and c-JUN
Aberrant reactivation of embryonic pathways is a common feature of cancer. RUNX2 is a transcription factor crucial during embryogenesis that is aberrantly reactivated in many tumors, including thyroid and breast cancer, where it promotes aggressiveness and metastatic spreading. Currently, the mechan...
Autores principales: | Sancisi, Valentina, Manzotti, Gloria, Gugnoni, Mila, Rossi, Teresa, Gandolfi, Greta, Gobbi, Giulia, Torricelli, Federica, Catellani, Francesca, Faria do Valle, Italo, Remondini, Daniel, Castellani, Gastone, Ragazzi, Moira, Piana, Simonetta, Ciarrocchi, Alessia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5737559/ https://www.ncbi.nlm.nih.gov/pubmed/28981843 http://dx.doi.org/10.1093/nar/gkx802 |
Ejemplares similares
-
HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms
por: Manzotti, Gloria, et al.
Publicado: (2019) -
Adding pieces to the puzzle of differentiated-to-anaplastic thyroid cancer evolution: the oncogene E2F7
por: Gugnoni, Mila, et al.
Publicado: (2023) -
Autophagy and epithelial–mesenchymal transition: an intricate interplay in cancer
por: Gugnoni, Mila, et al.
Publicado: (2016) -
Cadherin 6 Is a New RUNX2 Target in TGF-β Signalling Pathway
por: Sancisi, Valentina, et al.
Publicado: (2013) -
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas
por: Gandolfi, Greta, et al.
Publicado: (2017)